Skip to main content
. 2016 Sep 15;39(11):2011–2018. doi: 10.2337/dc16-0574

Table 2.

HRs of type 2 diabetes according to updated 4-year changes in dietary quality (categories in AHEI scores)

Decrease
No change or stable(±<3%) Increase
P for trend HR per 10% score increase
Moderate to large (>10%) Small to moderate(3–10%) Small to moderate(3–10%) Moderate to large (>10%)
NHS (1986–2010)
 Cases/person-years 358/61,075 870/176,310 1,477/300,169 1,074/226,534 529/109,284
 Model 1* 1.33 (1.18–1.50) 1.06 (0.97–1.15) 1.00 0.93 (0.85–1.00) 0.87 (0.78–0.96) <0.0001 0.86 (0.83–0.90)
 Model 2 1.27 (1.13–1.43) 1.04 (0.95–1.13) 1.00 0.95 (0.88–1.03) 0.89 (0.80–0.99) <0.0001 0.89 (0.85–0.93)
NHS II (1991–2011)
 Cases/person-years 258/47,760 539/127,070 1,143/265,994 705/189,609 491/129,739
 Model 1* 1.45 (1.25–1.67) 1.09 (0.97–1.21) 1.00 0.85 (0.77–0.94) 0.76 (0.67–0.85) <0.0001 0.81 (0.78–0.85)
 Model 2 1.31 (1.13–1.51) 1.03 (0.93–1.15) 1.00 0.88 (0.80–0.98) 0.77 (0.69–0.87) <0.0001 0.85 (0.81–0.89)
HPFS (1986–2010)
 Cases/person-years 118/27,668 340/83,582 734/176,678 470/116,985 255/54,959
 Model 1* 1.15 (0.93–1.41) 1.02 (0.89–1.17) 1.00 0.92 (0.81–1.04) 0.99 (0.85–1.16) 0.14 0.94 (0.87–1.00)
 Model 2 1.05 (0.86–1.30) 0.98 (0.86–1.13) 1.00 0.94 (0.83–1.07) 1.01 (0.86–1.18) 0.67 0.97 (0.91–1.04)
Pooled
 Model 1* 1.34 (1.23–1.46) 1.06 (1.00–1.13) 1.00 0.90 (0.85–0.94) 0.84 (0.78–0.90) <0.0001 0.85 (0.83–0.88)
 Model 2 1.25 (1.15–1.36) 1.03 (0.97–1.09) 1.00 0.93 (0.88–0.98) 0.86 (0.81–0.93) <0.0001 0.89 (0.86–0.91)

Values are reported as HR (95% CI), unless otherwise indicated.

*Model 1 was adjusted for age; ethnicity (white/nonwhite); family history of diabetes (yes/no); baseline AHEI score, physical activity, and total energy intake at the beginning of each 4-year period (all in quintiles); 4-year changes in smoking status (never to never, never to current, past to past, past to current, current to past, current to current, or missing indicator), physical activity, and total energy intake (all in quintiles); and a medical history of hypertension (yes/no) and hypercholesterolemia (yes/no). In the NHS and NHS II, postmenopausal status and postmenopausal hormone use (never use, current use, past use, or missing) were also included.

†Model 2 was adjusted for model 1 variables in addition to baseline BMI values at the beginning of each 4-year period (<21, 21–22.9, 23–24.9, 25–29.9, ≥30 kg/m2).